Spironolactone is associated with a reduction in the incidence of fractures among men with congestive heart failure

Source: Inpharma, Volume 1, Number 1647, 2008-07-19 , pp. 11-11(1)

Publisher: Adis International

Keywords: Congestive-heart-failure, treatment; Fracture, prevention; Spironolactone, therapeutic use

Document Type: Research article

Links for this article

http://www.ingentaconnect.com/adis/inp/2008/00000001/00001647/art00037
http://openurl.ingenta.com/content?genre=article&issn=1173-8324&volume=1&issue=1647&spage=11&epage=11